Telehealth services gained popularity last year with the onset of the COVID-19 pandemic. With social distancing becoming important, patients had to cancel in-person visits and resort to teleconsultation with their physicians or healthcare centers in order to avoid the risk of exposure to the virus.
Notably, the government in the United States stepped in to allow further access to telehealth during the crisis. Per a
factsheet by the Centers for Medicare & Medicaid Services, a new waiver was announced which allowed Medicare to pay, starting from Mar 6, 2020, for “office, hospital, and other visits furnished via telehealth across the country and including in patient’s places of residence.” Although the vaccine has been rolled out in the United States, the importance of telehealth seems poised to remain in the future given the convenience it provides.
report by Fortune Business Insights, the global telehealth market size is expected to reach $559.52 billion in 2027 from $61.40 billion in 2019, at a CAGR of 25.2% during the forecast period. The report mentioned that the cost-effective nature of teleconsultation, reduction in waiting time in outpatient departments and easy access were the factors that led to an increased preference for telehealth services. Furthermore, the report mentioned that the market size for telehealth in North America stood at $26.14 billion in 2019. The market in the region is set to be driven by the “preference for teleconsultation, strategic presence of key players, and favorable health reimbursements.”
Meanwhile, the report mentioned that one of the major driving factors behind the increasing popularity of telehealth services will be rise in healthcare costs across many countries. Notably, Statista estimated that U.S. health expenditure is set to reach
around $6.2 trillion in 2028.
Such a scenario bodes well for telehealth stocks since the expected rise in cost of healthcare is sure to lead patients to opt for the less-expensive teleconsultation services. In fact, per a
survey by McKinsey & Company last year, 76% of survey respondents had indicated that they were “highly or moderately likely to use telehealth” going forward. 3 Top Stocks to Watch
Even with the deployment of the vaccine in the United States, telehealth services are expected to continue their robust growth. This is because patients might opt for this cost-effective alternative in the face of rising healthcare expenses. Hence, this seems to be a good opportunity to look at stocks that offer telehealth services that stand to benefit from this trend going forward. Notably, we have selected three such stocks that carry a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). You can see
. the complete list of today’s Zacks #1 Rank stocks here 1Life Healthcare, Inc. ( ONEM Quick Quote ONEM - Free Report) operates a membership-based primary care platform. Its membership model includes seamless access to digital health services paired with inviting in-office care routinely covered under health insurance programs. The company currently has a Zacks Rank #1. The Zacks Consensus Estimate for its current-year earnings improved 14.5% over the past 90 days. The company’s expected earnings growth rate for the current year is 38.4%. Teladoc Health, Inc. ( TDOC Quick Quote TDOC - Free Report) provides virtual healthcare services on a business-to-business basis in the United States and internationally. The company currently has a Zacks Rank #2. The Zacks Consensus Estimate for its current-year earnings improved 5.8% over the past 90 days. The company’s expected earnings growth rate for the current year is 56.1%. Anthem, Inc. ( ANTM Quick Quote ANTM - Free Report) , through its subsidiaries, operates as a health benefits company in the United States. Notably, the company provides the option to consult with physicians online via its LiveHealth Online platform. The company currently has a Zacks Rank #3. The Zacks Consensus Estimate for its current-year earnings increased 0.9% over the past 60 days. The company’s expected earnings growth rate for the current year is 13.5%. Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>